The thrombotic and cardiovascular risk associated with JAK inhibitors remains debated, which is largely due to a lack of a clear mechanism associated to the therapeutic target that could explain the increased risk. In our analysis, we aimed to investigate if there may be a plausible off-target drug-effect. While the computational approaches identified several targets relevant for blood coagulation and platelet aggregation (e.g., Adenosine